abstract |
Compounds of formula (IA) are described wherein R 1 is 2-indanyl, R 2 is 1-methylpropyl, R 3 is 1-methyl indazol-5-yl, R 4 is methyl and R 5 is hydrogen or methyl, and pharmaceutically acceptable derivatives thereof, so as well as methods for their preparation, pharmaceutical compositions containing them and their use in medicine, especially use as oxytocin antagonists. |